Executive Protocol

Financial & Physiological Deployment Strategy

System Status

Attack Phase Active

Monthly Investment

R13 574

Average monthly burn (ZAR)

Target Outcome

10 – 20 kg

Physiological Delta

Muscle Status

GH Axis Primed

Anabolic Signaling

Aesthetics

Skin & Tan

Visual Optimization

Agent Weekly Dosage Monthly Requirement Est. Monthly Cost
Retatrutide
Triple Agonist Force		 3.0mg / Week 12mg / Month R8 400
CJC-1295 + Ipa
GH Secretagogue		 1.75mg / Week 7.5mg / Month R1 200
GHK-Cu (50mg)
Collagen Synthesis		 14.0mg / Week 60mg / Month R900
Melanotan 1
Eumelanin Control		 3.5mg / Week 15mg / Month R1 508
NAD+
Mitochondrial ATP		 150mg / Week 600mg / Month R1 566
Agent Weekly Dosage Monthly Requirement Est. Monthly Cost
Retatrutide
Insulin Sensitivity		 0.5mg / Week 2mg / Month R1 400
CJC-1295 + Ipa
Tissue Recovery		 0.6mg / Week 2.4mg / Month R384
GHK-Cu
Dermal Health		 2.3mg / Week 10mg / Month R150
Melanotan 1
Base Pigment		 1.0mg / Week 4mg / Month R402
NAD+
Cellular Vitality		 175mg / Week 750mg / Month R1 958

LeoLab™ Sourcing Logic

Retatrutide (Avg R3500/5mg) The primary investment. Dosage is titrated to appetite suppression and heart rate. High impact, high cost pivot point for the entire regimen.

NAD+ (R1305/500mg) Calculated based on 1.2 to 1.5 vials per month to ensure cellular repair remains high during the metabolic stress of rapid fat oxidation.

The Aesthetic Stack GHK-Cu and Melanotan 1 are relatively low-cost high-reward agents, preventing "Ozempic Face" while darkening skin tone via eumelanin stimulation.

Deployment Notes

  • ● Prices represent average monthly burn based on LeoLab™ SA retail rates as of Q1 2024.
  • ● Attack Phase assumes an aggressive 12-week deployment for maximum metabolic reset.
  • ● Maintenance Phase cuts Retatrutide by ~80%, pivoting to insulin management rather than aggressive lipolysis.
  • ● Total monthly figures include a 5% buffer for Bac Water and reconstitution peripherals.